HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 99/1/71    most recent 00448.2004v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (21) Citing Articles via Google Scholar Google Scholar Articles by Yimlamai, T. Articles by Park, S. Search for Related Content PubMed PubMed Citation Articles by Yimlamai, T. Articles by Park, S.

Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway

¹Department of Applied Physiology and Kinesiology, University of Florida, Gainesville; and ²Geriatric, Research, Education, and Clinical Center, Malcom Randall Veterans’ Affairs Medical Center, Gainesville, Florida

Submitted 28 April 2004 ; accepted in final form 15 March 2005

The ubiquitin-proteasome pathway is primarily responsible for myofibrillar protein degradation during hindlimb unweighting (HU). -Adrenergic agonists such as clenbuterol (CB) induce muscle hypertrophy and attenuate muscle atrophy due to disuse or inactivity. However, the molecular mechanism by which CB exerts these effects remains poorly understood. The aims of this study were to investigate whether CB attenuates HU-induced muscle atrophy through an inhibition of the ubiquitin-proteasome pathway and whether insulin-like growth factor I (IGF-I) mediates this inhibition. Rats were randomized to the following groups: weight-bearing control, 14-day CB-treated, 14-day HU, and CB + HU. HU-induced atrophy was associated with increased proteolysis and upregulation of components of the ubiquitin-proteasome pathway (ubiquitin conjugates, ubiquitin conjugating enzyme E2-14kDa, and 20S proteasome activity). Upregulation of the ubiquitin proteasome occurred in all muscles tested but was more pronounced in muscles composed primarily of slow-twitch fibers (soleus) than in fast-twitch muscles (plantaris and tibialis anterior). Although CB induced hypertrophy in all muscles, CB attenuated the HU-induced atrophy and reduced ubiquitin conjugates only in the fast plantaris and tibialis anterior and not in the slow soleus muscle. CB did not elevate IGF-I protein content in either of the muscles examined. These results suggest that CB induces hypertrophy and alleviates HU-induced atrophy, particularly in the fast muscles, at least in part through a muscle-specific inhibition of the ubiquitin-proteasome pathway and that these effects are not mediated by the local production of IGF-I in skeletal muscle.

hindlimb unweighting; protein degradation; insulin-like growth factor 1

This article has been cited by other articles:

				C.-n. Chen, D. A. Ferrington, and L. V. Thompson Carbonic anhydrase III and four-and-a-half LIM protein 1 are preferentially oxidized with muscle unloading J Appl Physiol, November 1, 2008; 105(5): 1554 - 1561. [Abstract] [Full Text] [PDF]

				G. S. Lynch and J. G. Ryall Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease Physiol Rev, April 1, 2008; 88(2): 729 - 767. [Abstract] [Full Text] [PDF]

				F. Kawano, Y. Matsuoka, Y. Oke, Y. Higo, M. Terada, X. D. Wang, N. Nakai, H. Fukuda, S. Imajoh-Ohmi, and Y. Ohira Role(s) of nucleoli and phosphorylation of ribosomal protein S6 and/or HSP27 in the regulation of muscle mass Am J Physiol Cell Physiol, July 1, 2007; 293(1): C35 - C44. [Abstract] [Full Text] [PDF]

				I. J. Smith and S. L. Dodd Muscle: Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle Exp Physiol, May 1, 2007; 92(3): 561 - 573. [Abstract] [Full Text] [PDF]

				A. M. Baviera, N. M. Zanon, L. C. Carvalho Navegantes, R. H. Migliorini, and I. d. C. Kettelhut Pentoxifylline inhibits Ca2+-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E702 - E708. [Abstract] [Full Text] [PDF]

				W. O. Kline, F. J. Panaro, H. Yang, and S. C. Bodine Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol J Appl Physiol, February 1, 2007; 102(2): 740 - 747. [Abstract] [Full Text] [PDF]

				A. R. Judge, A. Koncarevic, R. B. Hunter, H.-C. Liou, R. W. Jackman, and S. C. Kandarian Role for I{kappa}B{alpha}, but not c-Rel, in skeletal muscle atrophy Am J Physiol Cell Physiol, January 1, 2007; 292(1): C372 - C382. [Abstract] [Full Text] [PDF]

				E. E. Dupont-Versteegden, J. D. Fluckey, M. Knox, D. Gaddy, and C. A. Peterson Effect of flywheel-based resistance exercise on processes contributing to muscle atrophy during unloading in adult rats J Appl Physiol, July 1, 2006; 101(1): 202 - 212. [Abstract] [Full Text] [PDF]